Skip to main content
. 2014 Oct 3;87(1043):20140359. doi: 10.1259/bjr.20140359

Table 2.

Clinical information of patients in recurrence group

Prognostic indicators No. of patients (n = 13)
Gleason score
 6 0
 7 4
 8 2
 9 4
 10 3
T staging
 T2b 1
 T2c 2
 T3a 4
 T3b 3
 T4 3
Pre-treatment prostate-specific antigen (ng ml−1)
 ≤10 1
 10–20 2
 >20 10